These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Protection of penetrating corneal allografts from immune rejection. Engelstein JM; Herberman RB; Waltman SR Am J Ophthalmol; 1972 Aug; 74(2):311-5. PubMed ID: 4559898 [No Abstract] [Full Text] [Related]
24. The value of skin allografts in the evaluation of the rejection of liver allotransplants in pigs. Galmarini D; Vercesi G; Fassati LR; Montemagno M; Tarenzi L; Beffagna B; Puricelli C; Pisani F; Pucci C; Farina L Eur Surg Res; 1971; 3(5):340-7. PubMed ID: 4941671 [No Abstract] [Full Text] [Related]
25. Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier. Lance EM; Boyse EA; Cooper S; Carswell EA Transplant Proc; 1971 Mar; 3(1):864-8. PubMed ID: 4937982 [No Abstract] [Full Text] [Related]
26. Platelets levels during rat skin allograft rejection. Ballantine DL; Coburn RJ; Hawthorne GA Transplantation; 1972 May; 13(5):531-3. PubMed ID: 4557801 [No Abstract] [Full Text] [Related]
27. Cell-mediated hyperacute rejection. I. Acute, accelerated, and hyperacute reactions. Emam M; Eichwald EJ Transplantation; 1981 Mar; 31(3):156-9. PubMed ID: 7015608 [TBL] [Abstract][Full Text] [Related]
28. [The role of acetylcholine and adrenaline in the processes of skin graft rejection]. Mikhaĭlov VV; Zaĭtseva GV Patol Fiziol Eksp Ter; 1971; 15(2):65-9. PubMed ID: 4944940 [No Abstract] [Full Text] [Related]
29. Effects of cell membranes with and without antilymphocyte serum on skin and heart allograft survival. Matolo NM; Reemtsma K; Dewitt CW Transplantation; 1972 Mar; 13(3):265-9. PubMed ID: 4553728 [No Abstract] [Full Text] [Related]
30. Quantitative assessment of cellular and humoral responses to skin and tumor allografts. Canty TG; Wunderlich JR Transplantation; 1971 Feb; 11(2):111-6. PubMed ID: 4931236 [No Abstract] [Full Text] [Related]
31. Skin allografts in the newt, Notopthalmus viridescens: cessation of blood flow as an indicator of rejection. Hightower JA; St Pierre RL J Exp Zool; 1972 Sep; 181(3):341-52. PubMed ID: 4560032 [No Abstract] [Full Text] [Related]
32. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft. Petrányi G; Szegedi G; Fekete B Acta Med Acad Sci Hung; 1971; 28(2):155-8. PubMed ID: 4948114 [No Abstract] [Full Text] [Related]
33. Studies of leukergy in skin graft rejection in mice. Kowalczyk K; Plonkowa I; Rybczynska Z; Skowron-Cendrzak A Folia Biol (Krakow); 1973; 21(2):115-25. PubMed ID: 4582090 [No Abstract] [Full Text] [Related]
34. The role of the HLA-D (D and DR) locus in the rejection of allografts. Dausset J; Fauchet R; Suet C; Busson M; Schmid M; Hors J Adv Nephrol Necker Hosp; 1980; 9():223-35. PubMed ID: 6773313 [No Abstract] [Full Text] [Related]
35. Skin grafts and allogeneic tumor growth in mice. Colmerauer ME; Rumi L; Saal F; Pasqualini CD Medicina (B Aires); 1974; 34(5):471-5. PubMed ID: 4612291 [No Abstract] [Full Text] [Related]
36. Immunogenicity and enhancement of normal and tumor tissue in the mouse. McKenzie IF; Snell GD Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155 [No Abstract] [Full Text] [Related]